Lassa virus (LASV) is endemic in the rodent populations of Sierra Leone, Nigeria and other
countries in West Africa. Spillover to humans occurs frequently and results in Lassa fever, a …

Lassa fever (LF) is a zoonotic disease associated with acute and potentially fatal
hemorrhagic illness caused by the Lassa virus (LASV), a member of the family Arenaviridae …

The Lassa virus is endemic in parts of West Africa, and it causes hemorrhagic fever with high
mortality. The development of a recombinant protein vaccine has been hampered by the …

The arenavirus Lassa causes severe hemorrhagic fever and a significant disease burden in
West Africa every year. The glycoprotein, GPC, is the sole antigen expressed on the viral …

Developing potent therapeutics and effective vaccines are the ultimate goals in controlling
infectious diseases. Lassa virus (LASV), the causative pathogen of Lassa fever (LF), infects …

Lassa fever (LF), caused by Lassa virus (LASV), is a viral hemorrhagic fever for which no
approved vaccine or potent antiviral treatment is available. LF is a WHO priority disease and …

Development of broad-spectrum antiviral therapies is critical for outbreak and pandemic
preparedness against emerging and reemerging viruses. Viruses inducing hemorrhagic …

There are no approved treatments for Lassa fever, which is endemic to the same regions of
West Africa that were recently devastated by Ebola. Here we show that a combination of …

Lassa fever (LF) is a deadly viral hemorrhagic disease that is endemic to West Africa. The
causative agent of LF is Lassa virus (LASV), which causes approximately 300,000 infections …

Crimean-Congo hemorrhagic fever virus (CCHFV) is a widespread, tick-borne pathogen that
causes Crimean-Congo hemorrhagic fever (CCHF) with high morbidity and mortality …